25

Liquid Biopsy Market Outlook

https://www.renub.com

Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024. Renub Research report titled “Liquid Biopsy Market, by Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others), Product (Kits & Consumables, Instruments and Services), Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes), Sample (Plasma/Serum, Urine & Others), Clinical Application (Monitoring, Prognosis, Theranostics & Screening), Regions (North America, Europe, Asia-Pacific, Latin America and Middle East/Africa), Companies (Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics Inc., Genomic Health, NeoGenomics Laboratories, Qiagen)” provides a complete analysis of Global Liquid Biopsy Market.

Read »


Created by renubresearch 1 year 1 week ago – Made popular 1 year 1 week ago
Category: Health   Tags:

User login

EzySpot is a news/social bookmarking site.


Monetize Your Website

Syndicate

Syndicate content